Jesse Boumelha

7PUBLICATIONS
130CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 16, 2026
Dendritic cells control tertiary lymphoid structure development and maintenance in cancer.

|Sep 05, 2024
Hematopoietic aging promotes cancer by fueling IL-1⍺-driven emergency myelopoiesis.

Matthew D Park, Jessica Le Berichel, Pauline Hamon

|Apr 18, 2024
CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer.

Jesse Boumelha, Andrea de Castro, Nourdine Bah

|Dec 04, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.

Deborah R Caswell, Philippe Gui, Manasi K Mayekar

|Aug 15, 2023
Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy.

Jesse Boumelha, Miriam Molina-Arcas, Julian Downward

|Aug 05, 2022
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.

Jesse Boumelha, Sophie de Carné Trécesson, Emily K Law

Pageof 2

Frequent Collaborators

6 joint publications

Julian Downward

4 joint publications

Miriam Molina-Arcas

3 joint publications

Christopher Moore

3 joint publications

Philip East